20160128 EGA Regulatory and Scientific Affairs Conferenc

100% increase in Patient Access to Biologic Treatments thanks to Biosimilar Medicines

30 March 2016

Biosimilar medicines represent an essential opportunity to optimise patient access to […]

Read more

EGA becomes Medicines for Europe

10 March 2016

The European Generic and Biosimilar Medicines Association is now Medicines […]

Read more

IGBA calls for full transparency and new timelines for impact assessment with regard to the voluntary WHO biological qualifier (BQ) proposal

2 March 2016


Medicines for Europe: Better Access, Better Health

1 March 2016


EGA Prioritises Pursuing Sustainability Agreements

12 February 2016


The European Biosimilars Group Appoints New Leadership Team With Sandoz’ Carol Lynch and Polpharma’s Klaus Martin

10 February 2016

Last week in Brussels, the European Biosimilar medicines Group (EBG […]

Read more

Generic and Biosimilar Medicines Essential for Italian Healthcare System

8 January 2016

Brussels – Generic and biosimilar medicines represent an essential opportunity to […]

Read more

Les génériques rament pour accéder au marché

7 October 2015


A Comprehensive And Fair Solution To The Price Of Medicines

7 October 2015

After a long dry spell, the pharmaceutical research industry has […]

Read more

Subscribe to our newsletter